
Johnson & Johnson (JNJ) recently reported its third-quarter financials, with higher-than-expected revenue and earnings. It was the company’s first financial reporting since it spun off its consumer health business, Kenvue Inc. (KVUE).
In this piece, I have discussed why it could be wise to invest in JNJ following its third-quarter results.